5991 - 6000 of 9033 Results
Title
Year
- No anti-IgLON5 antibody in carefully diagnosed PSP patients with “atypical” or variant clinical features2025RESTRICTEDTitle: No anti-IgLON5 antibody in carefully diagnosed PSP patients with “atypical” or variant clinical featuresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108071End Page: 108071Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108071Citation Count: 0
-
OPENTitle: Interferon gamma stimulates coordinated changes in LRRK2, GCase, and cathepsin activities in idiopathic and genetic Parkinson’s disease monocytesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 337End Page: 337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01185-8Best OA location URL: https://www.nature.com/articles/s41531-025-01185-8.pdfCitation Count: 2
- Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease2013OPENTitle: Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 1Start Page: 13End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.08.021Best OA location URL: http://doi.org/10.1016/j.parkreldis.2013.08.021Citation Count: 8
- Jumping to overcome freezing of gait while turning in Parkinson's disease2019RESTRICTEDTitle: Jumping to overcome freezing of gait while turning in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 349End Page: 351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.04.021Citation Count: 2
-
OPENTitle: The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onsetJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 144.e1End Page: 144.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.07.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7736199Citation Count: 9
- MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP2017RESTRICTEDTitle: MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSPJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 46Issue #:Start Page: 47End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.020Citation Count: 55
-
OPENTitle: Akinetic rigid symptoms are associated with decline in a cortical motor network in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 19End Page: 19Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00120-3Best OA location URL: https://www.nature.com/articles/s41531-020-00120-3.pdfCitation Count: 35
- Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease2014RESTRICTEDTitle: Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1345End Page: 1351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.016Citation Count: 24
- Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease2019RESTRICTEDTitle: Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.020Citation Count: 19
-
OPENTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8369681Citation Count: 30